Director Melvin Sharoky, M.D., filed a Form 4 with the SEC on August 19, 2026, disclosing the sale of 5,000 shares of Insmed Inc common stock on August 17, 2026, through an indirectly held entity.

Key Highlights

  • Transaction: 5,000 shares of Insmed Inc common stock disposed of on August 17, 2026, through Padonia, LLC, of which Sharoky is the managing member.
  • Weighted average price: $127.53 per share, with individual sales ranging from $127.51 to $127.61 per share, according to the filing.
  • Post-transaction indirect holding via Padonia, LLC: 0 shares beneficially owned through that entity following the transaction.
  • Direct holdings: 246,081 shares of common stock held directly following the reported transaction.
  • Additional indirect holdings: 6,847 shares held by spouse; 819, 5,423, 5,007, and 3,724 shares held under separate UTMA custodial accounts.
  • Reporting person role: Sharoky is identified as a Director of Insmed Inc (NASDAQ:INSM).

Sharoky's Sale of Padonia, LLC Stake in Insmed Common Stock

According to the Form 4 filed August 19, 2026, Melvin Sharoky, M.D., a Director of Insmed Inc, disposed of 5,000 shares of Insmed common stock on August 17, 2026. The transaction was carried out through Padonia, LLC, an entity in which Sharoky serves as managing member. The filing reports a transaction code of "S," indicating a sale. Following the transaction, Padonia, LLC holds 0 shares of Insmed common stock.

The filing discloses that the reported price of $127.53 is a weighted average, with actual sales prices ranging from $127.51 to $127.61 per share. The filing notes that Sharoky "undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request."

Beyond the Padonia, LLC position, the filing details Sharoky's remaining beneficial ownership across several accounts. He holds 246,081 shares directly. An additional 6,847 shares are held indirectly by his spouse. He also serves as custodian for four UTMA accounts holding 819, 5,423, 5,007, and 3,724 shares, respectively, for Adler J. Wink, Nolan M. Wink, Sophie C. Wink, and Tulia L. Sharoky. The Form 4 was signed by Michael A. Smith as attorney-in-fact for Sharoky.

What Was Disclosed

Insmed Inc director Melvin Sharoky, M.D., disclosed the sale of 5,000 shares of common stock at a weighted average price of $127.53 through Padonia, LLC on August 17, 2026, leaving him with 246,081 shares held directly and additional indirect holdings across multiple accounts.